Michael Brian Bell - 15 Jan 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Financial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
15 Jan 2025
Net transactions value
-$48,938
Form type
4
Filing time
16 Jan 2025, 17:03:04 UTC
Previous filing
03 Jan 2025
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +3,309 +12% $0.000000 30,226 15 Jan 2025 Direct
transaction GH Common Stock Tax liability $48,938 -1,305 -4.3% $37.50 28,921 15 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -3,309 -100% $0.000000 0 15 Jan 2025 Common Stock 3,309 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vested 25% of the shares subject to such award on January 15, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.